FDA Import Refusal AEK-6495799-4/71/1 — BOEGRINGER INGELHEIM INDIA LIMIT
The FDA refused shipment AEK-6495799-4/71/1 from BOEGRINGER INGELHEIM INDIA LIMIT (India) on Sep 20, 2024. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal details
- Date
- Sep 20, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75